| 21/06/18 | 08:40:22 | 21 Jun 2018 | | Director/PDMR Shareholding | RNS |
| 20/06/18 | 15:05:49 | 20 Jun 2018 | | Second Price Monitoring Extn | RNS |
| 20/06/18 | 15:00:22 | 20 Jun 2018 | | Price Monitoring Extension | RNS |
| 20/06/18 | 09:43:24 | 20 Jun 2018 | | Holding(s) in Company | RNS |
| 18/06/18 | 16:42:21 | 18 Jun 2018 | | Holdings in Company | RNS |
| 15/06/18 | 17:40:51 | 15 Jun 2018 | | Second Price Monitoring Extn | RNS |
| 15/06/18 | 17:35:34 | 15 Jun 2018 | | Price Monitoring Extension | RNS |
| 14/06/18 | 12:05:44 | 14 Jun 2018 | | Second Price Monitoring Extn | RNS |
| 14/06/18 | 12:00:17 | 14 Jun 2018 | | Price Monitoring Extension | RNS |
| 14/06/18 | 08:00:03 | 14 Jun 2018 | | Biomarker analysis of Phase III INTEREST trial | RNS |
| 31/05/18 | 15:33:09 | 31 May 2018 | | Result of AGM | RNS |
| 31/05/18 | 08:00:07 | 31 May 2018 | | AGM Statement | RNS |
| 16/05/18 | 18:53:24 | 16 May 2018 | | PDMR Shareholding | RNS |
| 15/05/18 | 16:14:41 | 15 May 2018 | | Director/PDMR Shareholding | RNS |
| 15/05/18 | 15:05:14 | 15 May 2018 | | Second Price Monitoring Extn | RNS |
| 15/05/18 | 15:00:10 | 15 May 2018 | | Price Monitoring Extension | RNS |
| 15/05/18 | 14:16:39 | 15 May 2018 | | Holdings in Company | RNS |
| 11/05/18 | 17:51:49 | 11 May 2018 | | Holding(s) in Company | RNS |
| 11/05/18 | 14:37:00 | 11 May 2018 | | Holding(s) in Company | RNS |
| 11/05/18 | 14:34:19 | 11 May 2018 | | Holding(s) in Company | RNS |
| 11/05/18 | 08:00:04 | 11 May 2018 | | Update on the Phase III INTEREST trial | RNS |
| 10/05/18 | 11:05:03 | 10 May 2018 | | Notice of AGM | RNS |
| 09/05/18 | 17:40:40 | 9 May 2018 | | Second Price Monitoring Extn | RNS |
| 09/05/18 | 17:35:41 | 9 May 2018 | | Price Monitoring Extension | RNS |
| 09/05/18 | 13:54:33 | 9 May 2018 | | Holdings in Company | RNS |
| 08/05/18 | 10:05:36 | 8 May 2018 | | Second Price Monitoring Extn | RNS |
| 08/05/18 | 10:00:31 | 8 May 2018 | | Price Monitoring Extension | RNS |
| 08/05/18 | 08:00:14 | 8 May 2018 | | Top line data from the Phase III INTEREST trial | RNS |
| 08/05/18 | 08:00:10 | 8 May 2018 | | Final Results for the year ended 31 December 2017 | RNS |
| 25/04/18 | 13:43:01 | 25 Apr 2018 | | Holdings in Company | RNS |
| 21/03/18 | 07:00:08 | 21 Mar 2018 | | Notice of Full Year Results | RNS |
| 06/03/18 | 12:54:44 | 6 Mar 2018 | | Holding(s) in Company | RNS |
| 05/03/18 | 10:12:07 | 5 Mar 2018 | | Holding(s) in Company | RNS |
| 02/03/18 | 13:25:33 | 2 Mar 2018 | | Holding(s) in Company | RNS |
| 01/03/18 | 12:42:23 | 1 Mar 2018 | | Holdings in Company | RNS |
| 01/03/18 | 12:41:00 | 1 Mar 2018 | | Holdings in Company | RNS |
| 26/02/18 | 13:37:29 | 26 Feb 2018 | | Issue of Equity | RNS |
| 21/02/18 | 15:31:38 | 21 Feb 2018 | | Results of Placing & Issue of Equity | RNS |
| 21/02/18 | 07:00:07 | 21 Feb 2018 | | Faron hosts R&D Day today in London | RNS |
| 16/02/18 | 07:00:03 | 16 Feb 2018 | | Proposed Placing to raise up to £15m | RNS |
| 05/02/18 | 07:00:05 | 5 Feb 2018 | | Second Traumakine manufacturing site established | RNS |
| 01/02/18 | 07:00:14 | 1 Feb 2018 | | Faron Announces Clevegen Grant of European Patent | RNS |
| 29/01/18 | 07:00:04 | 29 Jan 2018 | | FDA grants Fast Track Designation for Traumakine® | RNS |
| 24/01/18 | 07:00:05 | 24 Jan 2018 | | FDA approval of Faron's Traumakine® IND | RNS |
| 19/12/17 | 07:00:04 | 19 Dec 2017 | | INFORAAA trial receives recommendation from IDMC | RNS |
| 14/12/17 | 07:00:07 | 14 Dec 2017 | | Faron announces R&D Day in February 2018 | RNS |
| 11/12/17 | 07:32:18 | 11 Dec 2017 | | Recruitment completed in Traumakine INTEREST Trial | RNS |
| 06/12/17 | 18:06:03 | 6 Dec 2017 | | Holding(s) in Company | RNS |
| 01/12/17 | 14:55:32 | 1 Dec 2017 | | Holdings in Company | RNS |
| 01/12/17 | 07:01:24 | 1 Dec 2017 | | Appointment of Chief Commercial Officer | RNS |
